Hongye Yao

No ORCID on file · 1 paper in corpus · active 2022

Study types

  • article 1

Condition tags

  • endometriosis 1
article 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.874973

Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the CYP3A subfamily of P450 enzymes, while minorly metabolized by CYP2C…